Cardio Diagnostics Holdings (CDIO) EBITDA Margin Growth (1y) (2023 - 2026)
Cardio Diagnostics Holdings (CDIO) EBITDA Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | -1,651.00 |
| 10 | Cardio Diagnostics Holdings | 6.14 Mn | 554,201.32 | - | -549,299.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -549,299.00 |
| Mar 31, 2026 | 10.69 Mn |
| Dec 31, 2025 | -755,135.00 |
| Sep 30, 2025 | -3.85 Mn |
| Jun 30, 2025 | -616,196.00 |
| Mar 31, 2025 | -14.74 Mn |
| Dec 31, 2024 | -456,869.00 |
| Sep 30, 2024 | -701,416.00 |
| Jun 30, 2024 | 13.17 Mn |
| Dec 31, 2023 | 22.13 Mn |